The Trump administration plans to ensure transparency and accuracy in drug ads, including by increasing the amount of information related to any product risks.
Related Posts
Even Mark Zuckerberg seems surprised by Meta’s pace of spending on AI
Meta CEO Mark Zuckerberg explained on the earnings call how the speed of Meta’s AI technology buildout led the company to lift guidance for capex.
Auto giants forced to confront some hard truths in the age of ‘polycrisis’
Top original equipment manufacturers are caught in a perfect storm.
10-year Treasury yield hovers above 4.3% as investors focus on the Fed’s rate decision
The benchmark 10-year Treasury yield was flat on Friday as investors look ahead to the Federal Reserve’s final meeting of the year.